1. Providing Digital Health Solutions for Respiratory Disease

2. Disclaimer

3. Company overview

4. Corporate snapshot

5. Targeting a large addressable market Respiratory disease diagnosis is the most common outcome from a doctor visit1

6. Rapid point-of-care acute diagnosis using ResAppDx

7. Clinically validated in Australia and the US

8. Healthcare is going digital Telehealth is the fastest growing area of healthcare – with up to half of consults for respiratory disease

9. COVID-19 has rapidly accelerated telehealth adoption The pandemic has highlighted a consumer push to digital health solutions

10. ResAppDx enables telehealth with remote diagnosis

11. Positioned to tap multiple market segments

12. Key partnerships to support growth

13. Sleep apnoea is the most common sleep breathing disorder1 and is significantly underdiagnosed

14. SleepCheck is a direct-to-consumer app for sleep apnoea screening

15. Growth strategy for SleepCheck

16. Significant near-term growth drivers

17. Summary

18. Thank you!